5-Amino-1MQ 50mg x 25ct
$120.00
Volume discounts
Auto-applied at checkout
Free shipping on orders of $200+
Compound Identity
COMPOUND NAME
5-Amino-1-MQ
SYNONYMS
5-amino-1-methylquinolinium, 5MQ
CAS NUMBER
685079-15-6
MOLECULAR FORMULA
C10H11N2+
MOLECULAR WEIGHT
~159.21 g/mol
STRUCTURE
Quinoline core with a methyl group at the 1-position and an amino group at the 5-position4.
PEPTIDE SEQUENCE
N/A; Not a peptide
CHEMICAL STRUCTURE

Molecular Formula: C10H11N2+
Source: PubChem
Mechanism of Action
5-Amino-1MQ acts as a highly selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), blocking the methylation of nicotinamide (a form of vitamin B3) using S-adenosyl methionine (SAM) as a methyl donor. By inhibiting NNMT, 5-Amino-1MQ increases cellular SAM and NAD+ levels, enhances NAD+ salvage pathway flux, activates SIRT-1, boosts oxidative phosphorylation (OXPHOS), and influences cellular energy homeostasis and epigenetic modifications. These metabolic shifts increase energy expenditure, suppress lipogenesis, and rejuvenate muscle stem cell function, providing a unique mechanism for combating obesity, fatty liver, and age-related muscle decline1-3.
Biological Activity
In animal models, 5-Amino-1MQ markedly reduces body weight and fat mass, improves insulin sensitivity, and reverses diet-induced hepatic steatosis and adiposity2,3. In aged mice, it nearly doubles muscle fiber size and enhances muscle stem cell proliferation, resulting in superior muscle regeneration post-injury1. At the cellular level, 5-Amino-1MQ promotes differentiation and metabolic reprogramming of precursor cells while being well-tolerated in repeated dosing studies4. It exhibits an IC50 of approximately 1 μM for NNMT inhibition4, with favorable pharmacokinetic properties.
Storage
- Store at 4°C in a dry, sterile, light-protected environment.
Drug Categories
Experimental metabolic modulator, NNMT inhibitor, anti-obesity agent, muscle regenerative enhancer.
Additional Notes
Summary Table
Disclaimer
For Research Use Only. Not intended for human or veterinary use. This compound is supplied solely for laboratory and R&D purposes.
Detailed Product Description
5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration. Preclinical studies have demonstrated that 5-Amino-1MQ effectively reprograms metabolism in key energy-regulating tissues: it counteracts obesity and associated fat accumulation, reduces pathological liver fat, and enhances the regenerative potential of aged skeletal muscle1-3. By blocking NNMT activity, it increases critical cellular metabolites (SAM, NAD⁺) that drive downstream increases in energy expenditure and metabolic health1-4. Further, it activates muscle stem cells, promoting tissue regeneration, and reverses insulin resistance in relevant animal models, all with good systemic tolerability1,2. In preclinical studies, 5-Amino-1MQ provides a powerful tool to dissect the cellular and molecular consequences of NNMT inhibition. Its unique profile makes it an attractive compound for exploring the therapy of metabolic disease and muscle aging, as well as evaluating the intricate links between metabolism, epigenetics, and tissue function1-4.
Research Highlights
Metabolic Regulation and Anti-Obesity Effects: Potent inhibition of nicotinamide N-methyltransferase (NNMT) increases cellular NAD⁺ and S-adenosylmethionine (SAM) levels, enhances polyamine flux, boosts energy expenditure, and suppresses lipogenesis; in diet-induced obese mice, 5-Amino-1-MQ significantly reduces total body weight, fat mass, and adipocyte size, while improving insulin sensitivity and glucose tolerance2,3.
Liver Health and Anti-Steatosis Activity: Reverses diet-induced hepatic steatosis by normalizing liver fat content to lean control levels, reduces liver adiposity by over 45%, improves hepatic metabolic profiles, and shifts lipid metabolism away from de novo synthesis toward enhanced fatty acid oxidation2.
Muscle Regeneration and Anti-Aging Benefits: Activates senescent muscle stem cells (muSCs) in aged muscle, promoting proliferation, fusion, and regeneration; nearly doubles muscle fiber cross-sectional area and increases muscle contractile strength by ~70%, restoring regenerative function to levels comparable to youthful muscle1.
Epigenetic and Cellular Reprogramming: By blocking NNMT-mediated methylation of nicotinamide, preserves NAD⁺ salvage pathway activity, increases SIRT-1 signaling, reduces histone deacetylation, and promotes metabolic reprogramming toward oxidative phosphorylation and glycolysis balance, supporting tissue repair and energy homeostasis1-4.
NNMT (Nicotinamide N-Methyltransferase) Inhibition
- Potently and selectively binds to the nicotinamide binding site of NNMT, blocking the methylation of nicotinamide using SAM4.
- Elevates NAD+ and S-adenosylmethionine (SAM) levels, shifting metabolic flux toward energy expenditure and away from fat storage1-4.
- Increases SIRT-1 activity as a result of enhanced NAD+ salvage, leading to beneficial epigenetic and metabolic reprogramming, including increased oxidative phosphorylation (OXPHOS) and muscle stem cell activation1-3.
- In adipose tissue, inhibition of NNMT suppresses de novo lipogenesis, normalizes fat content, and improves insulin sensitivity2-3.
- In skeletal muscle, promotes stem cell proliferation, regeneration, and muscle fiber hypertrophy post-injury1.
Pharmacokinetic Profile
Route of Administration
Oral
Half-Life
6-8 hours
- Route of Administration: Oral, Intravenous
- Dosing Frequency: Once per day
- Half-Life: ~6-8 hours
Formulation & Handling
- Soluble in saline.
- Store at 4°C in a dry, sterile, light-protected environment.
Selected Clinical Trial Activity
5-Amino-1MQ is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development. It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication. 5-Amino-1MQ is supplied strictly for laboratory research and investigational purposes only.
References
Quality & Purity
This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to ≥99% purity by HPLC with identity confirmed by mass spectrometry. A Certificate of Analysis (COA) is available for every batch. Learn about our full quality and testing process →
MORE RESEARCH PEPTIDES
Related Products
Vesugen 20mg
MOTS-C 40mg
